BACKGROUND
Uncertainty persists regarding the effects of intensive blood-pressure lowering in patients with type 2 diabetes.
METHODS
In this multicenter, open-label, randomized trial conducted in Brazil, patients with elevated blood pressure, type 2 diabetes, and high cardiovascular risk received intensive therapy ta...
K. Santo, E. Martins, Gisele S. Silva et al.· New England Journal of Medic...· 0 citations
BACKGROUND
Whether intensive blood-pressure control reduces cardiovascular risk after cerebrovascular events remains uncertain.
METHODS
In this multicenter, open-label, randomized trial conducted at 30 sites in Brazil, we assigned participants with elevated blood pressure and previous ischemic stroke or transient isc...
G. Silva, M. J. Machline-Carrion, K. Santo et al.· New England Journal of Medic...· 0 citations
Baxdrostat was effective in lowering systolic blood pressure, but increased the risk of hyperkalemia, which supports it as an alternative therapy for uncontrolled and resistant hypertension, with cautious use in patients at risk for hyperkalemia.
A. Bortolotto, P. Goncalves, L. Bortolotto· European Heart Journal· 0 citations
The OPTIMAL-STROKE trial will be the first adequately powered trial of intensive BP control in the prevention of major cardiovascular events in patients with a history of ischaemic stroke or TIA.
Gisele S. Silva, M. J. Machline-Carrion, K. Santo et al.· European Stroke Journal· 1 citation
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.